PETS
NASDAQPetMed Express Inc.
SectorConsumer StaplesIndustryRetail-Drug Stores and Proprietary Stores
Price$1.69-1.06 (-38.50%)
2026-03-042026-06-05
News · 26 weeks13+400%
2025-12-142026-06-07
Mix690d
- SEC Filings3(50%)
- Earnings2(33%)
- Other1(17%)
Latest news
25 items- SECSEC Form 10-K filed by PetMed Express Inc.10-K - PETMED EXPRESS INC (0001040130) (Filer)
- SECPetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial ResultsDELRAY BEACH, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2026. Fourth Quarter Fiscal 2026 Financial Highlights Compared to Prior Year Period Net sales of $42.8 million compared to $50.8 million in the prior year period, a decrease of 15.6%, primarily driven by a decline in prescription medication sales.Net loss of $4.1 million, or $(0.19) per diluted share, compared to a net loss of $11.6 million, or $(0.56) per diluted share, for the prior year period. The decrease in the net loss can be attributed to lower general and
- PRPetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day. Date: Tuesday, June 2, 2026Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast: 4Q Earnings Webcast A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through Jun
- SECPetMed Express Inc. filed SEC Form 8-K: Shareholder Director Nominations8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channelsDELRAY BEACH, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., doing business as PetMeds and parent company of PetCareRx (NASDAQ:PETS), today announced a strategic partnership with Rural King to launch a new pet pharmacy offering, expanding access to prescription medications, preventatives and pet health products for customers across Rural King's retail stores and digital platforms. Through the partnership, PetMeds will provide pharmacy infrastructure, licensed pharmacists and e-commerce capabilities to enable Rural King customers to conveniently access trusted medications and health solutions for their animals. The collaboration marks PetMeds' first large-scale white-label
- SECSEC Form 10-Q filed by PetMed Express Inc.10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- INSIDERDirector Fulgoni Gian returned 26,057 shares to the company, decreasing direct ownership by 16% to 132,299 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- SECPetMed Express Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - PETMED EXPRESS INC (0001040130) (Filer)
- SECAmendment: PetMed Express Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K/A - PETMED EXPRESS INC (0001040130) (Filer)
- SECSEC Form 10-Q filed by PetMed Express Inc.10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- SECSEC Form 10-Q filed by PetMed Express Inc.10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- PRCardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed ExpressCardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non-binding proposal to acquire PetMed Express, Inc. (NASDAQ:PETS) ("PetMeds") for $4.25 per share in cash, representing an implied equity value of approximately $89 million. The proposal was delivered to the Board of Directors of PetMed Express and is not subject to any financing contingency, reflecting Cardone Ventures' confidence in its ability to execute the transaction. Strategic Rationale Cardone Ventures views PetMeds as a strategically important acquisition that aligns with its core mission of acquiring, operat
- PRPetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments LimitedDELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company" or "PetMeds"), today confirmed that it has received an unsolicited and non-binding acquisition proposal from SilverCape Investments Limited, a Singapore-based investment firm, to acquire all of the outstanding shares of the Company for $4 per share in cash, subject to various conditions such as due diligence and the execution of a mutually acceptable definitive agreement, but not subject to any financing contingency. While PetMeds would typically not publicly comment on privately submitted and non-binding acquisition proposals, SilverCape h
- SECSEC Form DEF 14A filed by PetMed Express Inc.DEF 14A - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love ThemDELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle products designed for pet parents who want to give purposeful, practical gifts this season. Unlike traditional pet gifts such as toys or beds, PetMeds' giftable assortment focuses on products that improve pets' everyday health, comfort, safety, and happiness, making them ideal for the pet owner who has everything. "With more pet parents treating their furry friends like true members of the family, holiday gifting has shifted toward smart, we
- SECPetMed Express Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- SECAmendment: SEC Form 8-A12B/A filed by PetMed Express Inc.8-A12B/A - PETMED EXPRESS INC (0001040130) (Filer)
- SECPetMed Express Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Leadership Update, Other Events, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMeds Extends Existing Shareholder Rights PlanDELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today announced that its Board of Directors (the "Board") has unanimously approved an amendment to the Company's existing shareholder rights plan (the "Rights Plan"), pursuant to which the expiration date of the Rights was extended for one year from the close of business on December 2, 2025 until the close of business on December 2, 2026. All other terms and conditions of the Rights Plan remain unchanged. The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company
- INSIDERDirector Fulgoni Gian was granted 33,846 shares, increasing direct ownership by 27% to 158,356 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
- SECPetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - PETMED EXPRESS INC (0001040130) (Filer)
- PRPetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from NasdaqDELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company"), today announced preliminary second quarter fiscal year 2026 results and filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Form 10-Q for the quarter ended September 30, 2025 within the prescribed time period without unreasonable effort or expense. Preliminary Second Quarter Net Sales: For the fiscal second quarter ended September 30, 2025, net sales are estimated to range from $43.4 million to $44.5 million compared to $58.0 million (as restated) in the prior y
- SECSEC Form NT 10-Q filed by PetMed Express Inc.NT 10-Q - PETMED EXPRESS INC (0001040130) (Filer)
- INSIDERCAO and Interim CFO Krulik Douglas was granted 20,000 shares, increasing direct ownership by 40% to 70,000 units (SEC Form 4)4 - PETMED EXPRESS INC (0001040130) (Issuer)
PETS FAQ
6 questionsWhat does PetMed Express Inc. do?
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain...Where does PETS stock trade?
PetMed Express Inc. (PETS) is listed on NASDAQ.What sector and industry is PETS in?
PetMed Express Inc. operates in the Consumer Staples sector, Retail-Drug Stores and Proprietary Stores industry.What are analysts saying about PETS?
PetMed Express Inc. has had 6 recent analyst actions on file. The most recent action was from Lake Street: Buy with a $2000.00 price target on 2023-05-25. Recent price targets range from $2000.00 to $3200.00.What companies are similar to PETS?
Notable peers in the same industry include CVS (CVS Health Corporation), WBA (Walgreens Boots Alliance Inc.), GRDN (Guardian Pharmacy Services Inc.), RAD (Rite Aid Corporation), YI (111 Inc.). Compare PETS side-by-side with any of them on Quantisnow.How can I track PETS on Quantisnow?
Quantisnow aggregates PetMed Express Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PETS to receive live email and push alerts on every new disclosure.